BioCentury
ARTICLE | Clinical News

Symbicort regulatory update

February 1, 2017 9:45 PM UTC

FDA approved Symbicort budesonide/formoterol from AstraZeneca to treat asthma in children ages 6-11. The combination of budesonide, an inhaled steroid, and formoterol, a long-acting adrenergic recepto...